MAIA · AMEX
MAIA Biotechnology (MAIA) Stock Price & Fundamentals
MAIA Biotechnology (MAIA) closed at $720.19 on Oct 9, 2026, down 0.09% from the previous close of $720.85.
Share price, past year
1Y +27.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $720.19 |
| Sep 30, 2026 | $732.90 |
| Aug 31, 2026 | $695.76 |
| Jul 31, 2026 | $693.62 |
| Jun 30, 2026 | $699.75 |
| May 29, 2026 | $729.33 |
| Apr 30, 2026 | $691.46 |
| Mar 31, 2026 | $661.62 |
| Feb 27, 2026 | $629.32 |
| Jan 30, 2026 | $635.72 |
| Dec 31, 2025 | $626.62 |
| Nov 28, 2025 | $623.13 |
| Oct 31, 2025 | $574.14 |
Key statistics
- Market cap
- $43.80B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.63
- Revenue (TTM)
- —
- Net income (TTM)
- −$26.85M
- Shares outstanding
- 60.8M
- Dividend yield
- —
- 52-week range
- $556.52 – $747.84
MAIA Biotechnology's market cap is $43.80B, based on a share price of $720.19 and 60.8M shares outstanding as of Jun 30, 2026.
Financials
MAIA Biotechnology reported revenue of $0.00 for fiscal 2024.
MAIA Biotechnology reported a net loss of $22.40M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $0.00 | — | −$23.25M | — | −$1.05 | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | — | — | −$1.49 | — |
| FY2022ended Dec 31, 2022 | $0.00 | — | — | — | −$1.75 | — |
Company profile
- Name
- MAIA Biotechnology, Inc.
- Ticker
- MAIA
- Exchange
- AMEX
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 444 West Lake Street, Suite 1700, Chicago, IL 60606
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001878313
Recent SEC filings
- Oct 6, 2026
- Aug 10, 2026
- May 22, 2026
- May 14, 2026
- May 11, 2026
- Apr 16, 2026
- Apr 8, 2026
- Apr 2, 2026
Frequently asked questions
What is MAIA Biotechnology's stock price?
MAIA Biotechnology (MAIA) closed at $720.19 on Oct 9, 2026, down 0.09% from the previous close of $720.85.
What is MAIA Biotechnology's market cap?
MAIA Biotechnology's market cap is $43.80B, based on a share price of $720.19 and 60.8M shares outstanding as of Jun 30, 2026.
How much revenue does MAIA Biotechnology make?
MAIA Biotechnology reported revenue of $0.00 for fiscal 2024.
Does MAIA Biotechnology pay a dividend?
MAIA Biotechnology's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from MAIA Biotechnology, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures